Metal Arts (OTCMKTS:MTRT) Stock Moves Up Again: Soars 65% in a Week

September 13, 2021

When a stock emerges as one of the biggest movers in the micro cap segment then it is also perhaps the right time for investors to start taking a bigger interest in it. One such stock is that of Metal Arts (OTCMKTS:MTRT), which has emerged as a massive mover in recent days and rocketed to as much as $3.45 a share from triple zeroes not too long ago. The stock…

Read More >>

Healthier Choices Management Corporation (HCMC) Stock In Focus After The Recent Movement

September 13, 2021

As far as micro cap stocks are concerned, there have been many winners so far this years and the Healthier Choices Management Corporation (OTCMKTS:HCMC) stock has been one of the notable winners. Despite having climbed down from its highest level in 52 weeks that was hit in February, the stock is still one of the biggest micro cap gainers this year so far. However, last week, the stock was fairly…

Read More >>

DSG Global (DSGT) Stock Jumps To Multi-Month High: Here is Why

September 13, 2021

Last Friday the DSG Global (OTCMKTS:DSGT) stock ended up as one of the notable gainers as it ended the day with gains of 19%. However, more importantly, the rally on Friday took its gains for the whole week to a whopping 125%. In light of such massive gains, it might be a good idea for investors to note that last Thursday DSG Global had announced that Imperium Motor Company, its…

Read More >>

Starbucks (NASDAQ: SBUX) Plans A ‘Drive-Thru’ Future For 45% Of Stores By 2023 As It Succeeds Despite COVID-19 Delta Variant

September 10, 2021

Starbucks (NASDAQ: SBUX) succeeds against the COVID-19 Delta Variant by aggressively acting as a survivor and reading trends. While some fast-food chains struggle as the virus remains, Starbucks is moving to grow drive-thru options to a virus-wary public to 45% of its stores by 2023 compared to 35% today. In fact, 60% of all new units in the pipeline will have one — as Starbucks thinks this is a long-term…

Read More >>

CytoDyn (OTCMKTS:CYDY) Announces Treatment Of The First Patient In Its Pivotal Phase 3 Covid-19 Trial In Brazil

September 10, 2021

Late-stage biotechnology company, CytoDyn (OTCMKTS:CYDY), which is developing  Inc leronlimab, having potential for myriad  therapeutic indications, on September 9, 2021 announced treatment of the first patient in Phase 3 COVID-19 trial in Brazil for patients having severe symptoms. Interim analysis would be done in 28 days after enrolling 245 patients, 40% of the total patients enrolled in the trial. The phase 3 trial is being done for serious covid patients…

Read More >>

Eco Depot (OTCMKTS: ECDP) Jumps By 22.45% To $1.20 As Climate Shield Achieves ‘Excellent Results’ In Lab Tests

September 10, 2021

Eco Depot (OTCMKTS: ECDP) announced Wednesday (9/8/21) excellent ASTM test results for its Bronya Climate Shield Facade environmental thermal paint line product from its wholly owned subsidiary, Bronya Canada Group. Yesterday, its stock jumped 22.45% or $0.22 to $1.20. The rise reflects a +60% move in just the past two days. ECDP bounced off its May 2021 low of $0.75 earlier this week which could mean a start of a…

Read More >>

Relief Therapeutics Inc (OTCMKTS:RLFTF) Launches PKU GOLIKE(R) KRUNCH in Germany and Italy

September 10, 2021

Biopharmaceutical company, Relief Therapeutics Inc (OTCMKTS:RLFTF) on September 9, 2021, announced that APR Applied Pharma Research, the wholly owned subsidiary, has launched affiliates in Germany and Italy, PKU GOLIKE(R) KRUNCH, a convenient chewable tablet for the dietary management of phenylketonuria, a metabolic genetic disorder. Paolo Galfetti, Chief Executive Officer of APR and President of Relief Europe, said that the firm is addressing a vital need with flexible option for PKU….

Read More >>

Soligenix (NASDAQ:SNGX) Stock Turns Volatile After The Key Data

September 10, 2021

Soligenix (NASDAQ:SNGX) jumped 11% following the grant of the orphan drug designation from the FDA for its active product candidate hypericin in T-cell lymphoma treatment. The grant expands the company’s prior orphan drug designation for the active ingredient that permitted its uses in cutaneous T-Cell lymphoma treatment. For Soligenix shareholders, this is great news as the designation grant will open up hypericin for a broader market. Besides broader market access,…

Read More >>

RiceBran Technologies (NASDAQ:RIBT) Stock Continues to Move Lower: Here is Why

September 10, 2021

RiceBran Technologies (NASDAQ:RIBT) fell 12% after announcing a definitive agreement with an institutional investor to purchase securities. Once the agreement is finalized, the company will be eligible to receive gross proceeds of around $3 million, excluding any proceeds realized once the investor exercises warrants.  According to the agreement, the investor has agreed to purchase 2.3075 million common shares of the company at $0.65 per share. Equally, the investor will agree…

Read More >>

Eloxx Pharmaceuticals Inc. (NASDAQ:ELOX) Stock Resumes Another Round Of Rally: But Why?

September 10, 2021

Eloxx Pharmaceuticals Inc. (NASDAQ:ELOX) jumped 10% after the US FDA granted the company Fast track designation for its drug candidate, ELX-02, to treat patients with cystic fibrosis with nonsense alterations. Currently, the drug candidate is in second phase clinical studies in cystic fibrosis patients with the nonsense mutation in the CF transmembrane conductance regulator (CFTR) gene who don’t have any available efficient disease-modifying treatments available. Most importantly, the second phase…

Read More >>